Peptide Research Database

Tissue Repair & Regenerative

For Research Use Only. Not for Human or Veterinary Use.

Overview

Peptides studied for tissue repair, angiogenesis and extracellular-matrix remodeling — BPC-157, TB-500 (Thymosin β4), their synergy and a comparison page.

CompoundClassMechanismPrimary research targets
BPC-157Gastric pentadecapeptideNO modulation, VEGF/FGF, gastroprotectionTendon, ligament, GI, neural repair
TB-500 (Ac-SDKP)Thymosin β4 fragmentActin sequestration, VEGF upregulationWound, cardiac and muscle repair

How Tissue Repair Peptides Work

These peptides modulate the tissue-repair cascade through complementary routes. BPC-157 is studied for nitric-oxide-system modulation, angiogenic growth-factor upregulation and fibroblast activation; TB-500 — the Ac-SDKP fragment of Thymosin β4 — is an actin-sequestering peptide that drives endothelial and epithelial cell migration and angiogenesis. Studied alone or in combination, they cover angiogenesis, cell migration, inflammation resolution and extracellular-matrix remodeling.

1. Angiogenesis

Both upregulate VEGF/FGF; TB-500 drives endothelial-cell migration through actin binding.

2. Cell migration & proliferation

BPC-157 stimulates fibroblasts and keratinocytes; TB-500 promotes endothelial and epithelial migration.

3. Extracellular-matrix remodeling

BPC-157 upregulates collagen I/III synthesis; TB-500 modulates matrix-metalloproteinase activity.

4. Anti-inflammatory signalling

Downregulate TNF-α, IL-6 and IL-1β; upregulate IL-10 and TGF-β.

5. Anti-apoptotic effects

Activate PI3K/Akt and ERK1/2 survival signalling in stressed tissue.

Key Properties at a Glance

CompoundCAS numberMW (Da)LengthMechanismHalf-life
BPC-157137525-51-21419.5215 aaNO modulation, VEGF/FGF, gastroprotection~ 15 min
TB-500 (Ac-SDKP)77591-33-4500.524 aaActin sequestration, VEGF upregulation~ 2–6 h

Research Evidence Summary

Representative reported findings from the literature (qualitative). See each compound page for detail.

CompoundKey reported findingReference
BPC-157Faster tendon functional recovery vs controlsSikiric P et al.
BPC-157Protection against NSAID-induced gastric lesionsSikiric P et al.
BPC-157Accelerated wound closure and angiogenesisSeiwerth S et al.
TB-500Accelerated wound closure and angiogenesisMalinda KM et al., 1999
TB-500Improved post-injury cardiac functionBock-Marquette I et al., 2004
TB-500Enhanced corneal epithelial healingSosne G et al., 2005

Research Dosing Overview

Typical research dose ranges from the literature (for research reference only, not human dosing guidance):

CompoundResearch doseRouteFrequencyDuration
BPC-15710–50 µg/kgSC / oral1–2×/day2–8 wk
TB-500 (Ac-SDKP)1–5 mgSC / IM1–2×/wk4–8 wk

Formulation & Reconstitution

FactorRecommendation
SolventBacteriostatic water (0.9% benzyl alcohol)
Reconstitution1–2 mL per vial (peptide-dependent)
Storage (lyophilized)−20°C, desiccated, protected from light
Storage (reconstituted)2–8°C for up to 7–14 days
pH stability range5.0–7.0
Oxidation-sensitive residuesProtect Met / Cys peptides from air and light; add antioxidant where relevant

Selected References

  • Sikiric P, et al. Stable gastric pentadecapeptide BPC-157 (review and preclinical literature).
  • Malinda KM, et al. Thymosin beta-4 accelerates wound healing. Journal of Investigative Dermatology, 1999.
  • Bock-Marquette I, et al. Thymosin beta-4 promotes cardiac cell survival and repair. Nature, 2004.
  • Sosne G, et al. Thymosin beta-4 promotes corneal wound healing. Experimental Eye Research, 2005.

Need research-grade peptides?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote